A Health Canada safety review examines the potential risk of hepatotoxicity with oral ashwagandha products following international concerns about a possible association.
Study examines the association between initiation of GLP-1 RAs versus dipeptidyl peptidase-4 inhibitors and fragility fracture risk in adults with type 2 diabetes.
In a population-based study using Manitoba prescription dispensing records, my colleagues and I found that approximately 60% of individuals took at least one prescription medication postpartum.
All of the following statements about the new product Dyanavel XR (amphetamine 5 mg, 10 mg, 15 mg and 20 mg extended-release tablets) for treatment of attention deficit hyperactivity disorder are true, EXCEPT for . . .